Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C18H28O2 |
| Molecular Weight | 276.4137 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
C[C@]12CC[C@H]3[C@@H](CC=C4C[C@@H](O)CC[C@H]34)[C@@H]1CC[C@@H]2O
InChI
InChIKey=VVUQRXPUVKXAIO-XFUVECHXSA-N
InChI=1S/C18H28O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h2,12-17,19-20H,3-10H2,1H3/t12-,13-,14+,15+,16-,17-,18-/m0/s1
| Molecular Formula | C18H28O2 |
| Molecular Weight | 276.4137 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ABSOLUTE |
| Additional Stereochemistry | No |
| Defined Stereocenters | 7 / 7 |
| E/Z Centers | 0 |
| Optical Activity | UNSPECIFIED |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Detection and quantification of glucuro- and sulfoconjugated metabolites in human urine following oral administration of xenobiotic 19-norsteroids. | 2006-09 |
|
| Testosterone prohormone supplements. | 2006-08 |
|
| Quantitative determination of metabolic products of 19-norandrostenediol in human plasma using gas chromatography/mass spectrometry. | 2006-08 |
|
| Quantification and profiling of 19-norandrosterone and 19-noretiocholanolone in human urine after consumption of a nutritional supplement and norsteroids. | 2005-03 |
|
| Analytical strategies for the detection of non-labelled anabolic androgenic steroids in nutritional supplements. | 2004-07 |
|
| Oral andro-related prohormone supplementation: do the potential risks outweigh the benefits? | 2003-02 |
|
| Human nutritional supplements in the horse: comparative effects of 19-norandrostenedione and 19-norandrostenediol on the 19-norsteroid profile and consequences for doping control. | 2002-01-25 |
|
| [Urinary nandrolone metabolites in antidoping control]. | 2001-09 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:21:08 GMT 2025
by
admin
on
Mon Mar 31 22:21:08 GMT 2025
|
| Record UNII |
5N0V272KSA
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
DEA NO. |
4000
Created by
admin on Mon Mar 31 22:21:08 GMT 2025 , Edited by admin on Mon Mar 31 22:21:08 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID70703096
Created by
admin on Mon Mar 31 22:21:08 GMT 2025 , Edited by admin on Mon Mar 31 22:21:08 GMT 2025
|
PRIMARY | |||
|
25975-59-1
Created by
admin on Mon Mar 31 22:21:08 GMT 2025 , Edited by admin on Mon Mar 31 22:21:08 GMT 2025
|
PRIMARY | |||
|
19-Nor-5-androstenediol
Created by
admin on Mon Mar 31 22:21:08 GMT 2025 , Edited by admin on Mon Mar 31 22:21:08 GMT 2025
|
PRIMARY | |||
|
5N0V272KSA
Created by
admin on Mon Mar 31 22:21:08 GMT 2025 , Edited by admin on Mon Mar 31 22:21:08 GMT 2025
|
PRIMARY | |||
|
9900246
Created by
admin on Mon Mar 31 22:21:08 GMT 2025 , Edited by admin on Mon Mar 31 22:21:08 GMT 2025
|
PRIMARY | |||
|
DB01455
Created by
admin on Mon Mar 31 22:21:08 GMT 2025 , Edited by admin on Mon Mar 31 22:21:08 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
